Federal Register / Vol. 72, No. 141 / Tuesday, July 24, 2007 / Notices 40331 

and Explosives Programs Division 

(AEPD) of the Bureau of Alcohol, 

Tobacco, Firearms and Explosives 

distributes program-specific customer 

satisfaction surveys to more effectively 

capture customer perception/ 

satisfaction of services. AEPD’s strategy 

is based on a commitment to provide 

the kind of customer service that will 

better accomplish ATF’s mission. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: It is estimated that 500 

respondents will complete a 15 minute 

survey. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: There are an estimated 125 

annual total burden hours associated 

with this collection. 

If additional information is required 

contact Lynn Bryant, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Patrick Henry Building, 

Suite 1600, 601 D Street, NW., 

Washington, DC 20530. 

Dated: July 18, 2007. 

Lynn Bryant, 

Department Clearance Officer, PRA, 

Department of Justice. 

[FR Doc. E7–14244 Filed 7–23–07; 8:45 am] 

BILLING CODE 4410–FY–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—IMS Global Learning 

Consortium, Inc. 

Notice is hereby given that, on June 

15, 2007, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), IMS Global Learning 

Consortium, Inc. has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Agilix, Orem, UT; Florida 

Virtual Schools, Orlando, FL; Houghton 

Mifflin Company, Boston, MA; Sungard 

Higher Education, Malvern, PA; and 

Sun Microsystems, Inc., Broomfield, CO 

have been added as parties to this 

venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and IMS Global 

Learning Consortium, Inc. intends to file 

additional written notifications 

disclosing all changes in membership. 

On April 7, 2000, IMS Global 

Learning Consortium, Inc. filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on September 13, 2000 (65 FR 

55283). 

The last notification was filed with 

the Department on March 16, 2007. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on May 7, 2007 (72 FR 25781). 

Patricia A. Brink, 

Deputy Director of Operations, Antitrust 

Division. 

[FR Doc. 07–3592 Filed 7–23–07; 8:45 am] 

BILLING CODE 4410–11–M 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on May 23, 2007, 

American Radiolabeled Chemical, Inc., 

101 Arc Drive, St. Louis, Missouri 

63146, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in schedule 

I and II: 

Drug Schedule 

Gamma hydroxybutyric acid 

(2010).

I 

Ibogaine (7260) ............................ I 

Lysergic acid diethylamide (7315) I 

Tetrahydrocannabinols (7370) ..... I 

Dimethyltryptamine (7435) ........... I 

1-[1-(2-Thienyl) .............................

cyclohexyl]piperidine(7470) ..........

I 

Dihydromorphine (9145) ............... I 

Normorphine (9313) ..................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Amobarbital (2125) ....................... II 

Phencyclidine (7471) .................... II 

Phenylacetone (8501) .................. II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Metazocine (9240) ........................ II 

Drug Schedule 

Dextropropoxyphene, bulk (nondosage forms)(9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) ................... II 

Phenazocine (9715) ..................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

small quantities of the listed controlled 

substances as radiolabeled compounds 

for biochemical research. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such a substance 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections being sent via regular mail 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), Washington, DC 20537, or any 

being sent via express mail should be 

sent to Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 2401 Jefferson Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than September 24, 2007. 

Dated: July 10, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–14267 Filed 7–23–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on April 24, 2007, 

Applied Science Labs, Division of 

Alltech Associates Inc., 2701 Carolean 

Industrial Drive, State College, 

Pennsylvania 16801, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedule I and II: 

Drug Schedule 

Methcathinone (1237) .................. I 

N-Ethylamphetamine (1475) ........ I 

N,N-Dimethylamphetamine (1480) I 

4-Methylaminorex (cis isomer) 

(1590).

I 

Alpha-ethyltryptamine (7249) ....... I 

mstockstill on PROD1PC66 with NOTICES